CONMED Suffers Self-Inflicted Wound to End 2022

CONMED reported 4Q22 orthopedic sales of $115.2 million, -2% compared to the fourth-quarter of 2021. For the full year, the company attained orthopedic sales of $461.6 million, +5.3% compared to 2021.

Recently-acquired In2Bones and BioRez contributed nearly $25 million in sales for 2022.

In October, CONMED implemented a new warehouse...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0